Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/2011
07/27/2011CN102133215A Application of butylphenyl phthaleine in preparing medicament for treating chronic alcoholism
07/27/2011CN102133212A Asarone medical composition
07/27/2011CN102133211A Asarone medical composition as well as preparation method and preparation thereof
07/27/2011CN102133198A Ifenprodil tartrate freeze-dried powder injection and preparation method thereof
07/27/2011CN102133171A Methods for administering aripiprazole
07/27/2011CN102133018A Health care drug pillow
07/27/2011CN102132884A Preparation method of foods, beverages and medicines containing apocynum venetum extract
07/27/2011CN101954031B Medicament for treating vascular dementia and preparation method
07/27/2011CN101816712B Chinese medicinal composition for treating trigeminal neuralgia
07/27/2011CN101785823B Traditional Chinese medicine combination and preparation method for malaise, palpitation and insomnia treatment
07/27/2011CN101780244B Medicament composition for treating epilepsy
07/27/2011CN101780186B Medicine for curing brain dysfunction caused by traumatic brain injury
07/27/2011CN101773571B Preparation process of blood activating capsule
07/27/2011CN101757552B Application of jieyu pill in drug treatment
07/27/2011CN101700336B Chinese herba preparation for curing craniocerebra trauma residual headache and preparation method
07/27/2011CN101628108B Traditional Chinese medicinal granules for treating wind-cold evil and preparation method thereof
07/27/2011CN101584772B Traditional Chinese medicine for treating diabetes surrounding nerve lesion
07/27/2011CN101559274B Health care running machine and method for processing felt thereon
07/27/2011CN101538254B Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and therapeutic use
07/27/2011CN101480398B Use of ivabradine for the treatment of endothelial dysfunction
07/27/2011CN101472900B Therapeutic or prophylactic agent for multiple sclerosis
07/27/2011CN101466691B Substituted carboxamides as group I metabotropic receptor antagonists
07/27/2011CN101460460B Piperidine derivatives useful as serotonin transporter inhibitors and neurokinin-1 receptor antagonists
07/27/2011CN101417126B New use of OMI protein and coding gene thereof
07/27/2011CN101406593B Cigarette paste for giving up drugs
07/27/2011CN101357227B Senile dementia recombinant adenovirus gene vaccine and preparation method thereof
07/27/2011CN101342250B Bolus for clearing away heat of the upper part of the body
07/27/2011CN101296703B Extract of the family dioscoreaceae and composition for preventing or treating peripheral neuropathy comprising the same
07/27/2011CN101288693B Multifunctional health-care medical pillow for middle aged and old people
07/27/2011CN101249176B Chinese medicine prescription for steaming and soaking foots
07/27/2011CN101190268B Compound medicine for treating cervical spondylosis
07/27/2011CN101094687B Nutritional composition comprising immunoglobulin and oligosaccharides
07/26/2011US7985887 Regulation of endogenous gene expression in cells using zinc finger proteins
07/26/2011US7985760 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase
07/26/2011US7985754 Selective antagonists of A2A adenosine receptors
07/26/2011US7985753 Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulators
07/26/2011US7985747 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
07/26/2011US7985745 Including inflammatory pain, post surgical pain, and neuropathic pain; administering a histamine H4 receptor ligand alone or in combination with a histamine H1, H2, or H3 receptor antagonist or an enzyme inhibitor
07/26/2011US7985563 HIFαprolyl hydroxylation assay
07/26/2011US7985411 Activatable recombinant neurotoxins
07/26/2011CA2724295C Dibenzo (b,f) azepine intermediates
07/26/2011CA2629402C Beta-secretase modulators and methods of use
07/26/2011CA2510514C Alpha-aminoamide derivatives useful as antimigraine agents
07/26/2011CA2505937C Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropaties induced by anticancer agents
07/26/2011CA2499814C Strontium compound for treatment of sub-dermal soft tissue pain
07/26/2011CA2498785C Pyrrolidone derivatives as maob inhibitors
07/26/2011CA2498285C Aroyl-piperidine derivatives
07/26/2011CA2496308C Alkyl-substituted pyrazolopyrimidines
07/26/2011CA2487976C Calcitonin gene related peptide receptor antagonists
07/26/2011CA2484981C 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
07/26/2011CA2484482C Triple monoamine reuptake inhibitors for the treatment of chronic pain
07/26/2011CA2464333C Heteroindanes: a new class of potent cannabimimetic ligands
07/26/2011CA2427655C Use of alpha adrenergic receptor agonist to reduce a decrease in neurosensory retinal function following laser therapy for choroidal neovascularization
07/26/2011CA2367787C Ligands for metabotropic glutamate receptors
07/26/2011CA2215350C Transforming growth factor alpha hii
07/21/2011WO2011087804A2 Peptide-polynucleotide compositions, and methods for transfecting a cell with dna and treatment of neurodegenerative disease
07/21/2011WO2011087713A2 Tricyclic derivatives and their pharmaceutical use and compositions
07/21/2011WO2011087712A2 Tricyclic derivatives and their pharmaceutical use and compositions
07/21/2011WO2011087441A1 A pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
07/21/2011WO2011087393A1 Composition of vegetal origin for inhaling the smoke generated upon the combustion thereof
07/21/2011WO2011087187A1 Composition for protecting fetal nerve cells comprising vitamin c
07/21/2011WO2011087102A1 Therapeutic agent for promoting recovery of animal under medical treatment
07/21/2011WO2011086470A1 Treatment of multiple sclerosis
07/21/2011WO2011086377A1 PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS
07/21/2011WO2011086307A1 Pyrrolopyridine derivatives as nurr1 activators useful for treating parkinson's disease
07/21/2011WO2011086163A1 Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors
07/21/2011WO2011086126A1 Compounds for the treatment of autism
07/21/2011WO2011086099A1 Novel substituted triazole derivatives as gamma secretase modulators
07/21/2011WO2011086098A1 Novel substituted bicyclic triazole derivatives as gamma secretase modulators
07/21/2011WO2011086077A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
07/21/2011WO2011086047A1 Method for titrating clozapine
07/21/2011WO2011086007A1 Compositions comprising andrographics paniculata and gingko biloba extracts complexed with phospholipids
07/21/2011WO2011085886A1 Pyrrolidine derivatives
07/21/2011WO2011085701A1 Stable protein kinase activators, preparation methods and uses thereof
07/21/2011WO2011037833A3 Novel n-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents
07/21/2011WO2011034580A3 Small peptide modulators of potassium channel trafficking
07/21/2011WO2011028935A3 Methods of treating mitochondrial disorders using metalloporhyrins
07/21/2011WO2011028794A3 Treatment of huntington's disease with cycloserine and an nmda receptor antagonist
07/21/2011WO2011010084A3 Cyclosporin conjugates
07/21/2011WO2011009987A3 Aureolic acid derivatives, the method for preparation thereof and the uses thereof
07/21/2011WO2010151674A3 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
07/21/2011WO2010100512A8 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation
07/21/2011WO2010003760A3 Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity
07/21/2011WO2008097525A3 Local complement inhibition for treatment of complement-mediated disorders
07/21/2011US20110179502 Modulation of gm98 (mrf) in remyelination
07/21/2011US20110178294 Novel carboxylic acid derivatives, their preparation and use
07/21/2011US20110178179 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus
07/21/2011US20110178178 Treatment of Motor Fluctuations
07/21/2011US20110178177 Topical formulations for treatment of neuropathy
07/21/2011US20110178172 Inhibitors of Carnitin-Palmitoyl-Tranferase-1 for the Treatment and prevention of disorders caused by delipidation of neural tissue
07/21/2011US20110178166 Methods of using low-dose doxepin for the improvement of sleep
07/21/2011US20110178165 Tetrahydrofuranyl sulfonamides and pharmaceutical compositions thereof
07/21/2011US20110178151 Compounds and methods of treating obesity
07/21/2011US20110178150 Use of Indole Derivatives as NURR-1 Activators for Treating Parkinson's Disease
07/21/2011US20110178148 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
07/21/2011US20110178141 Thiazoliums and Their Use for Treating Protein Aging Associated Diseases
07/21/2011US20110178134 Novel phenyl-substituted imidazolidines, process for preparation thereof, medicaments comprising said compounds and use thereof
07/21/2011US20110178131 Compounds Which Have Activity At M1 Receptor And Their Uses In Medicine
07/21/2011US20110178128 Benzimidazole compound in crystal form and salt thereof
07/21/2011US20110178127 Amine compounds and medical uses thereof